2023-01-01 00:00:00
Metagenomics of the Gut Microbiome in Parkinson’s Disease: Prodromal Changes
Categories
View AllConditions
View AllDefinitions
View All
Amsel’s Criteria
Blood-Brain Barrier (BBB)
Bradford Hill Criteria
Coelomic Metaplasia Theory
Drug Repurposing
Endometriomas
Environmental Theory of Endometriosis
Estrobolome
Estrogen
Estrogen Receptors (ER)
Facultative Anaerobes
Fecal Microbiota Transplantation (FMT)
Genetic and Epigenetic Theory of Disease
Gram-Negative Bacteria
Idiopathic
Guides & Resources
View AllInterventions
View AllMicrobes
View AllMetals
View AllResearch Feeds
View All
Diagnosis of the menopause: NICE guidance and quality standards
Structured Exercise Benefits in Euthyroid Graves’ Disease: Improved Capacity, Fatigue, and Relapse
Gut microbiota modulation: a narrative review on a novel strategy for prevention and alleviation of ovarian aging
Dietary Intake and Ovarian Cancer Risk: A Systematic Review
Maternal Iron Deficiency Anemia Affects Postpartum Emotions and Cognition
Evidence for the Use of Complementary and Alternative Medicine for Pelvic Inflammatory Disease: A Literature Review
Prevalence of hot flushes and night sweats around the world: a systematic review
Vaginal microbiome of women with premature ovarian insufficiency: a descriptive cross-sectional study
Exercise for dysmenorrhoea
Black cohosh (Cimicifuga spp.) for menopausal symptoms.
Nifedipine for primary dysmenorrhoea
Drugs for the treatment of menopausal symptoms.
Does Physical Exercise Lower Endometriosis Risk? Systematic Review Insights
The Effects of Toxic Heavy Metals Lead, Cadmium and Copper on the Epidemiology of Male and Female Infertility
The role of probiotics in improving menstrual health in women with primary dysmenorrhoea
Karen Pendergrass, Standards Team
About
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease—four years before the first published case study.
Recent Posts
2023-01-01 00:00:00
Fibroblast growth factor 21 ameliorates behavior deficits in Parkinson’s disease mouse model via modulating gut microbiota and metabolic homeostasis2023-01-01 00:00:00
Exploring the alteration of gut microbiota and brain function in gender-specific Parkinson’s disease based on metagenomic sequencing2023-01-01 00:00:00
Gut microbiota-associated taurine metabolism dysregulation in a mouse model of Parkinson’s disease2023-01-01 00:00:00
Dysbiosis of the Beneficial Gut Bacteria in Patients with Parkinson’s Disease from India2023-01-01 00:00:00
Gut microbiome signatures reflect different subtypes of irritable bowel syndromeThis study explores gut microbiome signatures across BS subtypes, highlighting distinct microbial and metabolic shifts. Findings reveal subtype-specific dysbiosis, with implications for personalized dietary interventions and microbiome-targeted therapies for BS-D, BS-C, and BS-U patients.
2023-01-01 00:00:00
Multi-omics profiles of the intestinal microbiome in irritable bowel syndrome and its bowel habit subtypesThis study explores multi-omics profiles of the intestinal microbiome in BS subtypes, revealing distinct microbial and metabolic signatures. Findings highlight potential for microbiome-based diagnostics and targeted dietary interventions in BS-D, BS-C, and BS-M, enhancing personalized therapeutic strategies.
2023-01-01 00:00:00
Alternation of the gut microbiota in irritable bowel syndrome: an integrated analysis based on multicenter amplicon sequencing dataThis study explores the alteration of the gut microbiota in BS patients, revealing distinct microbial shifts linked to BS subtypes. Findings highlight potential for microbiome-based therapies and personalized intervention strategies to alleviate symptoms and restore gut health in BS-D, BS-C, and BS-M patients.
2023-01-01 00:00:00
Association of aberrant brain network dynamics with gut microbial composition uncovers disrupted brain-gut-microbiome interactions in irritable bowel syndrome: Preliminary findingsThis study identifies disrupted brain-gut-microbiome interactions in BS patients, revealing altered brain network dynamics and microbial shifts linked to symptom severity and cognitive dysfunction. These findings highlight the potential for targeted therapies addressing both brain connectivity and gut microbiota to improve BS management.
2023-01-01 00:00:00
Breast cancer patients from the Midwest region of the United States have reduced levels of short-chain fatty acid-producing gut bacteria